Glaukos (GKOS) News Today

Federated Hermes Inc. raised its position in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 68.2% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 21,862 shares of the medical instruments supplier's stock after buying an additional 8,863 sh

Seven Eight Capital LP acquired a new stake in Glaukos Co. (NYSE:GKOS - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 16,391 shares of the medical instruments supplier's stock, valued

Primecap Management Co. CA boosted its position in Glaukos Co. (NYSE:GKOS - Free Report) by 43.9% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,220,815 shares of the medical instruments supplier's stock after buying an additional 37

Glaukos (NYSE:GKOS) Stock Price Down 3.4%

Shares of Glaukos Co. (NYSE:GKOS - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the eleven research firms that are covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and eight have assigned a buy recommenda

Thornburg Investment Management Inc. purchased a new position in Glaukos Co. (NYSE:GKOS - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 30,103 shares of the medical instruments supplier's stock

Rhumbline Advisers lifted its stake in Glaukos Co. (NYSE:GKOS - Free Report) by 3.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 141,091 shares of the medical instruments supplier's stock after purchasi

Great Lakes Advisors LLC acquired a new position in shares of Glaukos Co. (NYSE:GKOS - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 117,656 shares of the medical instrument

Stifel Nicolaus raised their price target on shares of Glaukos from $130.00 to $145.00 and gave the stock a "buy" rating in a research report on Tuesday.

Bank of New York Mellon Corp grew its holdings in Glaukos Co. (NYSE:GKOS - Free Report) by 6.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 413,680 shares of the medical instruments supplier's stock after purchasing an additional 26,5

StockNews.com cut Glaukos from a "hold" rating to a "sell" rating in a report on Friday.

BTIG Research raised their price target on Glaukos from $131.00 to $139.00 and gave the stock a "buy" rating in a research note on Wednesday.

Legato Capital Management LLC trimmed its position in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 52.8% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,540 shares of the medical instruments supplier's st

Glaukos (NYSE:GKOS) Reaches New 52-Week High at $134.77

Glaukos Co. (NYSE:GKOS - Get Free Report) COO Joseph E. Gilliam sold 5,000 shares of Glaukos stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $129.36, for a total transaction of $646,800.00. Following the sale, the chief operating officer now directly owns 102,169 shares in the company, valued at approximately $13,216,581.84. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Glaukos Co. (NYSE:GKOS - Free Report) - Stock analysts at Zacks Research reduced their Q3 2024 earnings per share (EPS) estimates for shares of Glaukos in a report issued on Tuesday, August 20th. Zacks Research analyst I. Bandyopadhyay now forecasts that the medical instruments supplier will post

Glaukos (NYSE:GKOS) Hits New 12-Month High at $130.13

Glaukos Co. (NYSE:GKOS - Get Free Report) was the recipient of a large growth in short interest in the month of July. As of July 31st, there was short interest totalling 2,590,000 shares, a growth of 7.0% from the July 15th total of 2,420,000 shares. Based on an average daily volume of 535,500 shares, the days-to-cover ratio is currently 4.8 days.

Assenagon Asset Management S.A. purchased a new position in Glaukos Co. (NYSE:GKOS - Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 57,731 shares of the medical instruments supplier's stock, valued at approxi

Glaukos (NYSE:GKOS) Sets New 1-Year High at $127.51

Price T Rowe Associates Inc. MD cut its stake in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 90.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 30,364 shares of the medical instruments supplie

StockNews.com upgraded shares of Glaukos from a "sell" rating to a "hold" rating in a research report on Friday.